HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 2 filers reported holding HORIZON PHARMA PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 5.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,697,000 | +17.0% | 64,175 | -13.6% | 0.01% | 0.0% |
| Q4 2018 | $1,451,000 | +16.2% | 74,276 | +16.4% | 0.01% | +25.0% |
| Q3 2018 | $1,249,000 | -6.3% | 63,794 | -20.8% | 0.00% | 0.0% |
| Q2 2018 | $1,333,000 | +26.4% | 80,517 | +8.4% | 0.00% | +33.3% |
| Q1 2018 | $1,055,000 | -13.7% | 74,284 | -11.2% | 0.00% | -25.0% |
| Q4 2017 | $1,223,000 | +14.9% | 83,664 | -0.3% | 0.00% | +33.3% |
| Q3 2017 | $1,064,000 | +7.7% | 83,885 | +0.9% | 0.00% | 0.0% |
| Q2 2017 | $988,000 | +108.9% | 83,165 | +159.5% | 0.00% | +50.0% |
| Q1 2017 | $473,000 | -7.8% | 32,050 | +1.2% | 0.00% | 0.0% |
| Q4 2016 | $513,000 | -44.9% | 31,682 | -38.3% | 0.00% | -33.3% |
| Q3 2016 | $931,000 | +2065.1% | 51,373 | +1898.9% | 0.00% | – |
| Q2 2016 | $43,000 | -21.8% | 2,570 | -23.1% | 0.00% | – |
| Q1 2016 | $55,000 | -32.9% | 3,343 | -12.1% | 0.00% | – |
| Q4 2015 | $82,000 | -34.9% | 3,805 | -40.2% | 0.00% | -100.0% |
| Q3 2015 | $126,000 | -77.9% | 6,362 | -61.1% | 0.00% | -50.0% |
| Q2 2015 | $569,000 | -10.3% | 16,372 | -33.0% | 0.00% | 0.0% |
| Q1 2015 | $634,000 | – | 24,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
| KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
| CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
| EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
| USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
| Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
| C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
| Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
| Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
| FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |